CTX-712 is a potent inhibitor of cdc2-like kinase ( CLK ). CTX-712 inhibits CLK kinase activity, and thus inhibits cancer survival and cancer cell growth. CTX-712 has the potential for the research of cancer disease (extracted from patent JPWO2017188374A1, compound 286).
Form:Solid
仕様
仕様と純度
≥98%
生化学的・生理学的メカニズム
CTX-712 is a potent inhibitor of cdc2-like kinase ( CLK ). CTX-712 inhibits CLK kinase activity, and thus inhibits cancer survival and cancer cell growth. CTX-712 has the potential for the research of cancer disease (extracted from patent JPWO2017188374A1
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.